side effects glp 1 Potential metabolic and mechanism of GI effects of GLP-1 GLP-1 medications (Wegovy/Ozenpic, Zepbound/Moujaro) can

Insulin and leptin in the blood stream may be stimulated by novel therapeutics

Mikhailidis Current Pharmaceutical Design.2019

This landmark study led to FDA approval expansion in March 2024 for Wegovy (semaglutide 2.4 mg) to reduce the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with cardiovascular disease and either obesity or overweight

doi: 10.1002/hep.29367 184 BramanteCTignanelliCJDuttaNJonesETamarizLClarkJMet al

Gerstein, MD, MSc, FRCPC, professor and population health institute chair in diabetes research at McMaster University and Hamilton Health Sciences in Ontario, Canada, told Healio